IGC 1A
Alternative Names: IGC-1ALatest Information Update: 23 Sep 2024
At a glance
- Originator India Globalization Capital
- Class Antihyperglycaemics; Obesity therapies
- Mechanism of Action Glucagon-like peptide-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Obesity; Type 2 diabetes mellitus